Newly Approved Medication for Multiple Sclerosis

This is a one year study whose purpose is to collect information on overall treatment satisfaction in 1000 patients taking Aubagio© (Teriflunomide) for Relapsing Remitting Multiple Sclerosis.  This drug has been approved by the FDA in 2012.

  • Ages 18 years and older
  • May not currently be taking Aubagio¬© or have taken it in the past
  • Women of childbearing potential must be willing to use rigorous birth control